Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

By sjmartinez • April 12, 2024

Greenstein YY, Hubel K, Froess J, Wisniewski SR, Venugopal V, Lai YH, Berger JS, Chang SY, Colovos C, Shah F, Kornblith LZ, Lawler PR, Gaddh M, Guerrero RM, Nkemdirim W, Lopes RD, Reynolds HR, Amigo JS, Wahid L, Zahra A, Goligher EC, Zarychanski R, Leifer E, Huang DT, Neal MD, Hochman JS, Cushman M, Gong MN. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life. Chest. 2024 Apr;165(4):785-799. doi: 10.1016/j.chest.2023.11.019. Epub 2023 Nov 17. PMID: 37979717.

Tags: Anticoagulation, covid-19, Heparin, Publications, Pulmonary, Critical Care & Sleep Medicine, Quality of Life

Atrioventricular Dissociation With Ischemic-Appearing ST-Segment Changes

Hindosh Z, Roufeh E, Hayase J, Nguyen K. Atrioventricular Dissociation With Ischemic-Appearing ST-Segment Changes. JACC Case Rep. 2026 May 20;31(20):108039. doi: 10.1016/j.jaccas.2026.108039. PMID: 42165489.

Mirvetuximab Soravtansine Exposure and Incidence of Cataract Surgery

Silverstein JF, Smick A, Tsui E, Alomaja O, Johnson B, Tseng CH, Salani R, Slamon DJ, Chase DM, Konecny GE. Mirvetuximab Soravtansine Exposure and Incidence[...]

Evaluating the Predictive Utility of European-Based and Transethnic Polygenic Risk Scores for Kidney Function in Older Black Adults: Insights from the Health and Retirement Study

Cobb RJ, Thorpe RJ Jr, Norris KC. Evaluating the Predictive Utility of European-Based and Transethnic Polygenic Risk Scores for Kidney Function in Older Black Adults:[...]